ESO-26Homo sapiens (Human)Cancer cell line

Also known as: ESO26

🤖 AI SummaryBased on 4 publications

Quick Overview

Human esophageal adenocarcinoma cell line for cancer research.

Detailed Summary

ESO-26 is a human esophageal adenocarcinoma (EAC) cell line derived from a primary tumor. It is one of the 10 verified EAC cell lines that have been authenticated through genotyping and TP53 mutation analysis. These cell lines are used in research to study the molecular mechanisms of EAC and to develop targeted therapies. ESO-26 is part of a panel of cell lines that have been validated for their genetic consistency with the original tumors, ensuring their reliability for in vitro and in vivo studies. The cell line is available in public repositories to support cancer research and drug development.

Research Applications

Cancer researchMolecular mechanisms of EACDrug development

Key Characteristics

Authenticity verified through genotypingTP53 mutation analysisAvailable in public repositories
Generated on 6/18/2025

Basic Information

Database IDCVCL_2035
SpeciesHomo sapiens (Human)
Tissue SourceEsophagus, distal[UBERON:UBERON_0013473]

Donor Information

Age56
Age CategoryAdult
SexMale

Disease Information

DiseaseCarcinoma of esophagus
LineageEsophagus/Stomach
SubtypeAdenocarcinoma of the Gastroesophageal Junction
OncoTree CodeGEJ

DepMap Information

Source TypeSigma-Aldrich
Source IDACH-001496_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg248Trp (c.742C>T)HomozygousSomatic mutation acquired during proliferationfrom parent cell line VCaP

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
9,10
D13S317
9,11
D16S539
9
D18S51
17
D19S433
14
D21S11
30
D2S1338
19,23
D3S1358
15
D5S818
12
D7S820
11
D8S1179
13,14
FGA
21
Penta D
10
Penta E
12,14
TH01
9
TPOX
7,9
vWA
14,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.

Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.

Nature 568:511-516(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Whole-genome sequencing of nine esophageal adenocarcinoma cell lines.";

Lynch A.G., Edwards P.A.W., Fitzgerald R.C.

F1000Research 5:1336.1-1336.12(2016).

Translational research on esophageal adenocarcinoma: from cell line to clinic.

Boonstra J.J., Tilanus H.W., Dinjens W.N.M.

Dis. Esophagus 28:90-96(2015).

Verification and unmasking of widely used human esophageal adenocarcinoma cell lines.

Shimada Y., van Dekken H., Tilanus H.W., Dinjens W.N.M.

J. Natl. Cancer Inst. 102:271-274(2010).